Science News

ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the presentation of new clinical data from the global Phase 2 clinical trial (AP-101-02) evaluating the company’s lead program, AP-101, in patients with ALS. AP-101 is an investigational human-derived antibody directed against misfolded superoxide dismutase 1 (SOD1). AP-101 is...

LOS ANGELES--(BUSINESS WIRE)--AltaSea at the Port of Los Angeles, the world’s leading tech hub for the blue economy, today announced the appointment of businessman and philanthropist Jon Sutton Day to its Board of Trustees, effective March 31. A lifelong Angeleno, Day currently serves on the Board of Directors of the W.M. Keck Foundation, one of the nation’s largest philanthropic foundations supporting medical research, science and engineering, and educational programs. He is on the Foundation’...

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics launches Dyno Psi-Phi, an agentic AI suite for protein binder design, at NVIDIA GTC 2026...

SALT LAKE CITY--(BUSINESS WIRE)--The addition of APEXecm reflects Kolosis's continued commitment to developing and commercializing best-in-class solutions for the surgical community....

RALEIGH, N.C.--(BUSINESS WIRE)--On February 13, 2026, QHP Capital, L.P. (“QHP”) announced the closing of a $1.1 Billion single-asset continuation vehicle for Azurity Pharmaceuticals, Inc. (“Azurity”). The transaction provides liquidity to existing limited partners while enabling QHP to maintain control and continue executing on Azurity’s long-term value creation plan. The transaction was led by HarbourVest Partners, LLC (“HarbourVest”), with Pantheon Ventures, L.P. participating as a significan...

NEW YORK--(BUSINESS WIRE)--Sunrise Group, a pioneer in medical device innovation and sleep care, today announced results from the SUNSAS clinical study, now published in The Lancet Regional Health – Europe, a leading international medical journal. Supported by the French Ministry of Health through the Forfait Innovation program, this study is the largest randomized controlled trial to date evaluating an at-home diagnostic pathway for obstructive sleep apnea (OSA) compared with gold-standard pol...

BERKELEY, Calif.--(BUSINESS WIRE)--The AI revolution in biology is built on a foundation of openness —researchers sharing data, code, and ideas freely so that others can build on them....

MANHASSET, N.Y.--(BUSINESS WIRE)--For patients living with Systemic Lupus Erythematosus (SLE), their immune systems mistakenly attack themselves, unleashing dangerous and painful levels of inflammation. For many, the goal is to reach remission, when symptoms disappear. While remission often means an end to obvious symptoms, scientists are exploring if it signifies complete healing, or if underlying issues, particularly in the brain, might still be “simmering” unnoticed. To study this, scientist...

AUSTIN, Texas--(BUSINESS WIRE)--BetterUp®, the AI-powered human transformation company and inventor of virtual coaching, today announced its speaker lineup for Uplift, an immersive two-day summit where global enterprise leaders, leading researchers and cultural visionaries gather to exchange ideas, engage in debate and uncover new insights around AI readiness, leadership, talent retention, growth, and performance. This year's theme, "Agents of Change," spotlights the forward-thinking leaders th...

BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the global leader in clinical-grade AI-powered pathology, today announced the launch of Ibex 4, its next-generation platform. Built on Ibex’s clinically validated algorithms1-10 and developed in close collaboration with the world’s leading pathology labs, Ibex 4 is designed to transform the diagnostic journey, delivering unprecedented value to pathologists, laboratories, and patients. As pathology departments worldwide face rising case vol...